AA
SAGE

AQR Arbitrage’s Sage Therapeutics SAGE Stock Holding History

AQR Arbitrage’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-409,055
Closed -$3.73M – 491
2025
Q2 		$3.73M Buy
+409,055
New +$3.01M 0.09% 189

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AQR Arbitrage's SAGE Position: Q3 2025 in Review

AQR Arbitrage sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 409,055 shares — an estimated $3.73M sold.

AQR Arbitrage first reported a position in SAGE in Q2 2025 and held it in 1 quarter. The position peaked at $3.73M in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • AQR Arbitrage reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • AQR Arbitrage sold 409,055 Sage Therapeutics shares in Q3 2025, an estimated $3.73M.
  • AQR Arbitrage first reported a position in Sage Therapeutics in Q2 2025 and held it in 1 quarter.
  • AQR Arbitrage's Sage Therapeutics position peaked at $3.73M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on AQR Arbitrage's 13F filing for Q3 2025, filed 14 Nov 2025.